Chou-Zheng, L., & Hatoum-Aslan, A. (2019). A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity. eLife.
استشهاد بنمط شيكاغوChou-Zheng, Lucy, و Asma Hatoum-Aslan. "A Type III-A CRISPR-Cas System Employs Degradosome Nucleases to Ensure Robust Immunity." ELife 2019.
MLA استشهادChou-Zheng, Lucy, و Asma Hatoum-Aslan. "A Type III-A CRISPR-Cas System Employs Degradosome Nucleases to Ensure Robust Immunity." ELife 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.